Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.55 |
| ▸ | THPO | P40225 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | ACE | P12821 | 1/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 3/20 | 0.38 |
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | FNTA | P49354 | 2/20 | 0.36 |
| ▸ | FNTB | P49356 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4305909 | 1.00 | KDM4E (0.55) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL29587402 | 0.84 | TSHR (0.42) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL8379982 | 0.82 | TSHR (0.43) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL8379983 | 0.82 | TSHR (0.43) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL27619146 | 0.81 | KDM4E (0.57) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL6513640 | 0.81 | TGFBR1 (0.52) | TSHRCA1CA2ALDH1A1MAPK1 | |
| SCHEMBL6513633 | 0.81 | TGFBR1 (0.52) | TSHRCA1CA2ALDH1A1MAPK1 | |
| SCHEMBL29285204 | 0.80 | KDM4E (0.57) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL4289576 | 0.80 | KDM4E (0.42) | KDM4EMAPTTHRBALOX15NFKB1 | |
| SCHEMBL29285206 | 0.80 | KDM4E (0.57) | KDM4EMAPTTHRBALOX15NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024051132-A1 | COLCHICINE HYDROGEL MICRONEEDLE AND PREPARATION METHOD THEREFOR | 安徽中医药大学 | 2024-03-14 | — | — | WO | claimed |
| US-12558432-B2 | Biocompatible polymeric drug carriers for delivering active agents | CIS BIOPHARMA AG (CH) | 2026-02-24 | — | — | US | disclosed |
| EP-3296327-B1 | METHOD FOR PRODUCING ELLIPTICAL, NEEDLE-SHAPED, OR ROD-SHAPED POLYMER PARTICLES | NISSHINBO HOLDINGS INC (JP) | 2024-05-15 | — | — | EP | disclosed |
| CN-112105651-B | Method for producing disk-shaped polymer particles | 日清纺控股株式会社 | 2023-03-21 | — | — | CN | disclosed |
| US-20220409737-A1 | BIOCOMPATIBLE POLYMERIC DRUG CARRIERS FOR DELIVERING ACTIVE AGENTS | CIS BIOPHARMA AG (CH) | 2022-12-29 | — | — | US | disclosed |
| CN-110325173-B | Skin cosmetic | 日清纺控股株式会社 | 2022-06-14 | — | — | CN | disclosed |
| CN-114245881-A | Photosensitive resin composition | 日产化学株式会社 | 2022-03-25 | — | — | CN | disclosed |
| CN-114174351-A | Resin composition | 日产化学株式会社 | 2022-03-11 | — | — | CN | disclosed |
| US-11225541-B2 | Production method for disc-shaped polymer particles | NISSHINBO HOLDINGS INC. (JP) | 2022-01-18 | — | — | US | disclosed |
| US-20210246250-A1 | PRODUCTION METHOD FOR DISC-SHAPED POLYMER PARTICLES | NISSHINBO HOLDINGS INC. (JP) | 2021-08-12 | — | — | US | disclosed |
| US-20050271875-A1 | Composite particle with a carbodimide resin layer and process for producing the same | NISSHINBO INDUSTRIES, INC. (JP) | 2005-12-08 | — | — | US | disclosed |
| EP-1553124-A1 | FLAKY PARTICLES AND PROCESS FOR PRODUCTION THEREOF | Nisshinbo Industries, Inc. (JP) | 2005-07-13 | — | — | EP | disclosed |
| US-20050118424-A1 | particles comprising thermoplastic resins impregnated with carbodiimide compounds, having heat and solvent resistance, used as curing agents, stabilizers, hardeners, adhesives, coatings, paints, reinforcements and in automobiles, electronics, furniture, construction materials and as spacers | TAKAHASHI IKUO (JP) | 2005-06-02 | — | — | US | disclosed |
| EP-1528077-A1 | COMPOSITE PARTICLE HAVING CARBODIIMIDE RESIN LAYER AND PROCESS FOR PRODUCING THE SAME | Nisshinbo Industries, Inc. (JP) | 2005-05-04 | — | — | EP | disclosed |
| US-6866934-B2 | A thermoplastic resin having a functional group and carbodiimide compound impregnated only in the surface layer section or both surface layer section and inside the base particle and both are strongly bonded by crosslinking reaction | NISSHINBO INDUSTRIES, INC. (JP) | 2005-03-15 | — | — | US | disclosed |
| EP-1508042-A2 | BIOCHIPS WITH SURFACES COATED WITH POLYSACCHARIDE BASED HYDROGELS | Ciphergen Biosystems, Inc. (US) | 2005-02-23 | — | — | EP | disclosed |
| US-20030218130-A1 | Biochips with surfaces coated with polysaccharide-based hydrogels | CIPHERGEN BIOSYSTEMS, INC. | 2003-11-27 | — | — | US | disclosed |
| US-20030215636-A1 | A thermoplastic resin having a functional group and carbodiimide compound impregnated only in the surface layer section or both surface layer section and inside the base particle and both are strongly bonded by crosslinking reaction | NISSHINBO INDUSTRIES, INC. (JP) | 2003-11-20 | — | — | US | disclosed |
| WO-2003093785-A2 | BIOCHIPS WITH SURFACES COATED WITH POLYSACCHARIDE BASED HYDROGELS | CIPHERGEN BIOSYSTEMS, INC. (US) | 2003-11-13 | — | — | WO | disclosed |
| EP-1344795-A2 | Carbodiimide-containing hardening type reactive particles, process for producing the same, and use of the same | NISSHINBO INDUSTRIES, INC. (JP) | 2003-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12558432-B2 | Biocompatible polymeric drug carriers for delivering active agents | MSR1, CD47, SLC43A1 | KDM4E 3537/4885MAPT 4632/4885THRB 1407/4885 |
| US-20220409737-A1 | BIOCOMPATIBLE POLYMERIC DRUG CARRIERS FOR DELIVERING ACTIVE AGENTS | CD47, DNPEP, MSR1 | KDM4E 2133/4885MAPT 3895/4885THRB 3282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.